Type B insulin resistance syndrome with systemic lupus erythematosus

Clinical Nephrology

Volumn 73, Issue 2, 2010, Pages 157-162

  Sato, N ^a   Ohsawa, I ^a   Takagi, M ^a   Gohda, T ^a   Horikoshi, S ^a   Shirato, I ^a   Yamaguchi, Y ^b   Tomino, Y ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperglycemia; Hypoglycemia; Lupus nephritis; Podocytic shedding; SLE; Type B insulin resistance syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN G; INSULIN; LA ANTIBODY; PREDNISOLONE; RO ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE CLEARANCE; DRUG DOSE REDUCTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PANCYTOPENIA; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TYPE B INSULIN RESISTANCE SYNDROME; URINE SEDIMENT;

EID: 76649094913     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP73157     Document Type: Article

References (22)

1. Flier JS, Khan CR, Roth J. Receptors. antireceptor antibodies and mechanisms of insulin resistance. N Engl J Med. 1979; 300: 413-419.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725.
3. Kahn CR, Flier JS, Bar RS et al. The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man. N Engl J Med. 1976; 143: 739-745.
4. Moller DE, Flier JS. Insulin resistance: mechanisms, syndromes, and implications. N Engl J Med. 1991; 325: 938-948.
5. Flier JS, Kahn CR, Roth J, Bar RS. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science. 1975; 190: 63-65.
6. Gorden P, Collier E, Roach P. Autoimmune mechanisms of insulin resistance and hypoglycemia. In: Moller DE (ed.). Insulin Resistance. Chichester: Wiley; 1993. 123-142.
7. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P. Clinical course of the syndrome of autoantibodies to the insulin receptor (Type B insulin resistance): a 28-year perspective. Medline (Baltimore). 2002; 81: 87-100.
8. Selinger S, Tsai J, Pulini M, Saperstein A, Taylor S. Autoimmune thrombocytopenia and primary billiary cirrhosis with hypoglycemia and insulin receptor autoantibodies. Ann Interm Med. 1987; 107: 686-688.
9. Taylor SI, Grunberger G, Marcus-Samuels B, et al. Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med. 1982; 307: 1422-1426.
10. Khokher MA, Avasthy N, Taylor AM, Fonseca VA, Dandona P. Insulin-receptor antibody and hypoglycemia associated with Hodgkin's disease [letter]. Lancet. 1987; 1: 693-694.
11. Blecher M. Receptors, antibodies and disease. Clin Chem. 1984; 30: 1137-1156.
12. Nagayama Y. Morita H. Komukai D. Watanabe S, Yoshimura A. Type B insulin resistance syndrome induced by increased activity of systemic lupus erythematosus in a hemodialysis patient. Clin Nephrol. 2008; 69: 130-134.
13. Coll AP, Thomas S, Mufti GJ. Rituximab therapy for the Type B syndrome of severe insulin resistance [letter]. N Engl J Med. 2004; 350: 310-311.
14. George C, Curtis B, James E. Lupus Nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Annals of internal medicine. 1985; 102: 176-181.
15. Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007, 536-537.
16. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983; 24: 377.
17. Dreyer EO, Muldiyarov PY, Nassonova VA, Alekberova ZS. Endothelial inclusions and "nuclear bodies" in systemic lupus erythematosus. Ann Rheum Dis. 1973; 32: 444.
18. Goodman JR, Sylvester RA, Talal N, Tuffanelli DL. Virus-like structures in lymphocytes of patients with systemic and discoid lupus erythematosus. Ann Intern Med. 1973; 79: 396.
19. Haustein UF. Tubular structures in affected and normal skin in chronic discoid and systemic lupus erythematosus: Electron microscopic studies. Br J Dermatol. 1973; 89: 1.
20. Howat AJ, Pitt MA, Gibson SP, Coward RA. Membranous nephropathy with intramembranous spherical microparticles. Lab Invest. 2000; 80: 175A .
21. Kowalewska J, Smith KD, Hudkins KL, Chang A, Fogo AB, Houghton D, et al. Membranous glomerulopathy with spherules: an uncommon variant with obscure pathogenesis. Am J Kidney Dis. 2006; 47: 983.
22. Joh K, Taguchi N, Kobayashi Y, Sato H, Nishi S, Katafuchi R, wr al. A preliminary report of national research on podocytic infolding glomerulopathy. Jpn J Nephrol. 2007; 49: 61.